The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model-Reference-Cited by-同舟云学术

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

Published:2002-04-15 Issue:8 Volume:109 Page:1013-1020
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Semsarian Christopher,Ahmad Imran,Giewat Michael,Georgakopoulos Dimitrios,Schmitt Joachim P.,McConnell Bradley K.,Reiken Steven,Mende Ulrike,Marks Andrew R.,Kass David A.,Seidman Christine E.,Seidman J.G.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference34 articles.

1. Hypertrophic Cardiomyopathy

2. The Management of Hypertrophic Cardiomyopathy

3. Causes of sudden death in competitive athletes

Cited by 258 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic Spectrum of Subclinical Sarcomere-Related Hypertrophic Cardiomyopathy and Transition to Overt Disease;Circulation: Genomic and Precision Medicine;2024-08

2. Reduced connexin-43 expression, slow conduction and repolarisation dispersion in a model of hypertrophic cardiomyopathy;Disease Models & Mechanisms;2024-08-01

3. Gene transfer of human cardiomyopathy β-MyHC mutant R403Q directly alters intact cardiac myocyte calcium homeostasis and causes hyper-contractility;2024-07-31

4. Substrate mechanics unveil early structural and functional pathology in iPSC micro-tissue models of hypertrophic cardiomyopathy;iScience;2024-06

5. Allele-specific dysregulation of lipid and energy metabolism in early-stage hypertrophic cardiomyopathy;Journal of Molecular and Cellular Cardiology Plus;2024-06